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The stepped wedge (SW) cluster randomized design has been increasingly employed by
pragmatic trials in health services research. In this study, based on the GEE approach, we
present a closed-form sample size that is applicable to both closed-cohort and cross-sectional
SW trials with outcomes from the exponential family. Importantly, the proposed method
is flexible to accommodate design issues routinely encountered in pragmatic trials, such as
different within- and between-subject correlation structures, irregular crossover schedules for
the switch to intervention, and missing data due to repeated measurements over prolonged
follow-up. The closed-form formula also allows researchers to analytically assess the impact
of different design factors on sample size requirement. We also recognize the potential issue
of limited numbers of clusters in pragmatic SW trials and present an adjustment approach
for underestimated variance of the intervention effect. We conduct extensive simulation to
assess the performance of the proposed sample size method. An application example to a
real clinical trial is presented.
Bayesian group sequential design is one of the popular adaptive designs and has been ap-
plied widely in clinical studies, especially in phase II and III studies. It is flexible and efficient
in allowing early termination based on the accumulated data through Bayesian framework.
However, so far there is no discussion on its application in SW cluster randomized trials,
which become more pragmatic and popular in clinical and health care delivery studies. In
this study, we proposed a Bayesian adaptive design for cross-sectional SW cluster randomized
v
trials. It is more adaptable than traditional designs because it allows early termination of the
trial when interim data indicate that the intervention is sufficient efficacious or inefficacious.
A decision to terminate or continue the trial will be made on the basis of the predictive prob-
ability. This probability is the chance of getting a conclusive result at the end of the study
based on the interim data collected so far. We illustrate the early termination criteria and
determine the design parameters subject to the constraints of power and type I error. The
simulation studies show that the proposed method achieves good operating characteristics.
We present an example using our proposed method for illustration purpose.
vi
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Chapter 1
OVERVIEW OF STEPPED WEDGE CLUSTER RANDOMIZED TRIALS
Stepped wedge cluster randomized trials (SW-CRTs) have been increasingly employed
in health services research (Mhurchu et al., 2013; Bailet et al., 2009; Bacchieri et al., 2010;
van Holland et al., 2012). They have a unique feature that allows stepwise introduction of
interventions to a population, making it suitable to examine the effectiveness of interventions
in real-life practice (Hussey and Hughes, 2007; Brown and Lilford, 2006). Figure 1.1 provides
an illustration of the stepped wedge cluster randomized design. The horizontal axis indicates
time and the vertical axis indicates the sequences. Each sequence includes one or more
clusters of subjects, for example, formed by physicians and clinics. All clusters receive
control treatment at the start and cross over to receive the intervention from a randomly
assigned time onwards. Outcomes are measured at every time point (or step).
Figure 1.1. An illustration of a SW-CRT with T = 5 time points and S = 4 sequences (Each
cell represents a data collection point. Shaded and blank cells represent intervention and
control, respectively.)
1
SW-CRTs have several advantages. First, by switching all clusters to intervention by
the end of the study, it mitigates ethical dilemma of withholding an effective intervention
when the intervention is believed to be superior to the control (Edwards, 2013). Second, it
is more efficient because the evidence of effectiveness is provided by comparisons from two
directions: vertical comparisons of clusters between intervention and control at each time
point, and horizontal comparisons of observations before and after switching to intervention
within each cluster (Hargreaves et al., 2015). Third, outcomes are measured longitudinally,
offering insight into the temporal trend of intervention effect. On the other hand, SW-
CRTs present various challenges to researchers, which include longer study duration, higher
risk of attrition, and difficulty in blinding. For example, the correlation structure is much
more complicated than that in parallel cluster randomized designs. There are intracluster
correlation among subjects from the same cluster as well as longitudinal correlation among
measurements obtained over time from the same subjects. Moreover, the proportion of
missing data is usually higher due to repeated measurements over a longer duration, which
cannot be ignored in the design.
There are three major types of SW-CRTs (Copas et al., 2015; Beard et al., 2015; Martin
et al., 2016). The first is called closed-cohort, where all subjects are followed through the
study hence longitudinal measurements are collected from the same individuals. The second
is called cross-sectional, where subjects selected for measurements at a specific time point
will not be selected again in the future. The third is called open-cohort, where some subjects
are followed through the study, while others can leave or join in mid-study.
2
Chapter 2
SAMPLE SIZE DETERMINATION FOR SW-CRTS USING GEE
2.1. Introduction
Many researchers have investigated sample size calculation methods for cross-sectional
SW-CRTs (Hussey and Hughes, 2007; Hemming et al., 2015; Woertman et al., 2013; Moulton
et al., 2007), where the correlation structure is simpler. There have been relatively fewer
publications on sample size methods for closed-cohort SW-CRTs, some of which were purely
simulation-based (Baio et al., 2015), some based on the linear mixed-effect model approach
(Hooper et al., 2016; Girling and Hemming, 2016), and some based on the Bayesian method
(Cunanan et al., 2016). Li et al. (2018) proposed a sample size determination procedure for
closed-cohort SW-CRTs using the generalized estimating equations (GEE) approach (Liang
and Zeger, 1986), which considered a block exchangeable correlation structure defined by
three types of correlations: within-period, inter-period, and within-individual correlations.
It is noteworthy that all existing methods only consider ideal scenarios such as no missing
data, which are unlikely to hold in pragmatic trials conducted in the settings of real world
clinical practice.
In this study we investigate sample size calculation for SW-CRTs within the context of
pragmatic trials. Based on the GEE approach, we derived closed-form sample size formulas
for SW-CRTs with outcomes from exponential family, which can be applied to either the
closed-cohort or cross-sectional SW-CRTs by modifying the correlation structures. The
proposed sample size method is flexible to address pragmatic issues such as missing data due
to various mechanisms, complicated correlation structures, or arbitrary crossover schemes.
Specifically, (1) we introduce the GEE approach for SW-CRTs with continuous outcomes;
(2) we derive closed-form sample size formulas that accommodates various pragmatic design
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issues, such as unbalanced randomization of clusters, correlation structures, and missing
data; (3) we conduct simulation studies to assess the performance of the proposed method
under various designing configurations; (4) we illustrate the proposed method with a real
example; (5) we extend the proposed method to SW-CRTs with outcomes from exponential
family; and (6) we conclude with a discussion of proposed method.
2.2. Generalized estimating equations
We consider a closed-cohort SW-CRT with continuous outcomes. Suppose there are n
clusters and T steps. Each cluster is randomly assigned to one of the S sequences (S =
T − 1). Let Yijt be the continuous response obtained at time t (t = 1, . . . , T ) from subject
j (j = 1, . . . , J) of the ith cluster (i = 1, . . . , n), where J is the number of subjects in
each cluster. Thus N = nJ is the total number of subjects. A linear model is assumed for
Yij = (Yij1, . . . , YijT )
′:
E (Yij) = λ+ uiζ = Xiβ, (2.1)
where λ = (λ1, . . . , λT )
′ contains time-specific intercepts that implies a flexible model for
the temporal trend under control; ui = (ui1, . . . , uiT )
′
represents the treatments received
by cluster i over time, with uit = 0/1 denoting control/intervention; and ζ is a scalar
parameter representing the intervention effect, which is assumed to be constant over time.
We define Xi = (IT ,ui) to be the subject-specific design matrix, where IT denotes the T ×T






is the vector of regression coefficients. Depending on
randomization, we have P (ui = vs) = ps (s = 1, . . . , S), where
v1 = (0, 1, 1, . . . , 1, 1)
′
,










s=1 ps = 1. Under the above specification, the proportion of subjects receiving inter-
vention at step t is ūt =
∑S
s=1 psvst. Here vst is the tth element of vs. Accordingly, we define
the vector u = (u1, . . . , uT ).
We assume Var (Yijt) = σ
2. For each cluster, we use Corr (Yij) = Ω to denote longitudinal
(or within-subject) correlation and Corr (Yij, Yij′) = Φ for j 6= j′ to denote between-subject
correlation within the same cluster. We assume the subjects to be independent across clus-










Corr (Yi) = IJ ⊗ (Ω−Φ) + (1J1′J)⊗Φ. (2.2)
Here ⊗ indicates the operation of Kronecker product, IJ denotes a J × J identity matrix,
and 1J is a vector of length J with all elements being 1.
The primary interest is to test the null hypothesis H0 : ζ = 0. We estimate parameters
based on the GEE approach using an independent working correlation structure, which serves
as an instrument to facilitate the estimating process. The estimates remain consistent but
the computation is much simpler and more stable in terms of convergence (Crowder, 1995).
It has also been demonstrated that in many situations the resulting estimates are highly
efficient (Liang and Zeger, 1986; McDonald, 1993) and successfully employed in sample size
calculation (Ahn et al., 2014; Zhang et al., 2018; Lou et al., 2017; Zhu et al., 2017). The

















Under mild regularity conditions (Liang and Zeger, 1986), as n → ∞, √n(β̂ − β) →

























Here êij = Yij − Xiβ̂ is the residual and c⊗2 = cc′ for a vector c. The null hypothesis
H0 : ζ = 0 is rejected if
√
n ˆ|ζ|/σ̂ζ > z1−α/2, where ζ̂ is the (T + 1)th element of β̂, σ̂2ζ is the
(T + 1, T + 1)-component of Σn, and z1−α/2 is the 100 (1− α/2)th percentile of the standard
normal distribution.
2.3. Sample size calculation














s [Ω+ (J − 1)Φ]Ws,




s=1 ps (vs − ū)
′
[Ω+ (J − 1)Φ] (vs − ū)
J
[∑T
t=1 ut (1− ut)
]2 .
Under true intervention effect ζ0, to reject the null hypothesis H0 : ζ = 0 with power 1− γ







s=1 ps (vs − ū)
′
[Ω+ (J − 1)Φ] (vs − ū)
ζ20J
[∑T
t=1 ut (1− ut)
]2 , (2.3)
Details of derivation are presented in Appendix.
We have a few observations about sample size (2.3). First, by introducing notations
of Ω and Φ, as well as ps and vs, the proposed sample size provides great flexibility for
researchers to account for complicated correlation structures and arbitrary crossover sched-
ules encountered in real world SW-CRTs. Furthermore, it is noteworthy that time-specific
intercepts (λ) are not involved in Equation (2.3). That is, the temporal trend under control
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approximately has negligible impact on sample size requirement for SW-CRTs with contin-
uous outcomes. Because all clusters receive control at Step 1 and experimental intervention
at Step T , it is obvious that the first elements of vs (s = 1, · · · , S) and ū all take value 0,
and the last elements all take value 1. In turn, the first and last elements of (vs − ū) equal
0 for s = 1, · · · , S. From this observation we have the following fact:
Fact: Define Y ∗ij = (Yij2, · · · , Yij(T−1))′, Ω∗ = Corr(Y ∗ij ), and Φ∗ = Corr(Y ∗ij ,Y ∗ij′),
where j 6= j′. The correlation matrices Ω and Φ affect sample size (2.3) only through sub-
matrices Ω∗ and Φ∗.
This fact is particularly meaningful for special scenarios where T = 3 or T = 4. Under
T = 3, between-subject correlation Φ affects sample size only through Corr(Yij2, Yij′2), while
within-subject correlation Ω has no effect. Under T = 4, within-subject correlation Ω affects
sample size only through Corr(Yij2, Yij3). Hence whether Ω has a CS or AR(1) correlation
structure will lead to the same sample size as long as Corr(Yij2, Yij3) remains the same. The
expressions of sample size (2.3) under T = 3 and T = 4 are presented in Appendix.
Traditionally researchers have assumed a balanced randomization scheme. That is, ps =
1
S








s=1 (vs − ū)
′




The correlation matrices Ω and Φ can be specified directly based on preliminary knowledge.
Alternatively, their specification can be motivated by linear mixed-effect models. For exam-
ple, when the model includes cluster and patient random effects, the implied within-subject
(longitudinal) correlation matrix Ω is compound symmetric (CS) with off-diagonal elements









Sσ2 [(S − 2) ρ1 + S (J − 1) ρ2 + 2]
ζ20J (S
2 − 1) . (2.5)
The derivation of (2.4) and (2.5) is presented in Appendix. It is noteworthy that sample size
(2.5) is a linear function of ρ1 and ρ2. Equation (2.5) also shows that the coefficient of ρ1
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is S − 2, which is much smaller than the coefficient of ρ2, S(J − 1), under moderate cluster
sizes. Hence the between-subject correlation ρ2 has greater impact on sample size than







2 − 1) .
This lower limit for the number of clusters as J → ∞ suggests that, in practice, increasing
enrollment within existing clusters (increasing J) cannot always compensate for the lack of
participation of unique clusters.
The above sample size derivation is presented in the context of closed-cohort SW-CRTs.
It can easily accommodate cross-sectional SW-CRTs through the specification of Ω and Φ.
Under the cross-sectional stepped wedge design, the observations obtained at each step are
contributed by different panels of subjects from the same clusters. The resulting correlation
structure is characterized by Ω = 11
′
ρ + (1 − ρ)I and Φ = 11′ρ, as considered by Hussey
and Hughes (2007). Here ρ is the intracluster correlation coefficient (ICC). The required

















t=1 ut (1− ut)
]2 . (2.6)
Under the special case of ps =
1
S






Sσ2 [(JS − 2)ρ+ 2]
ζ20J (S
2 − 1) . (2.7)
Details of derivation are presented in Appendix.
The problem of missing data is frequently encountered in clinical trials. For closed-cohort
SW-CRTs, this problem is particularly pronounced due to the prolonged follow-up. Here we
present an extension to sample size (2.3) that accommodates missing data and still has
a closed form. First we introduce missing data indicator ∆ijt, which takes value 0 or 1 for
missed or observed measurement from the jth subject within the ith cluster at time t. Under
























where ∆ij = (∆ij1, . . . ,∆ijT )
′
, diag (c) is a diagonal matrix with c being the diagonal
elements, and ◦ indicates the operation of Hadamard product. Specifically, for two matrices
M1 and M2 of the same dimension, the (i, j)th-component of M1 ◦ M2 is the product of
(i, j)th-component of M1 and (i, j)th-component of M2. We assume that P (∆ijt = 1) = δt.
We further define the joint probability of observing measurements at both time t and t′
as P (∆ijt∆ijt′ = 1) = δtt′ . Usually the occurrence of missing data increases over time,
hence δ1 ≥ · · · ≥ δT . Given the same set of marginal missing probabilities, there can be
different missing data patterns. For example, missed visits cause missing values to occur
independently over time, which is called the independent missing (IM) pattern with δtt′ =
δtδt′ for t 6= t′, and δtt = δt. On the other hand, patient dropout leads to a pattern such
that once a patient misses a measurement, all his/her subsequent measurements are missing.
This is called the monotone missing (MM) pattern with δtt′ = δt′ for t ≤ t′, and δtt = δt.















δ̃ ◦Ω+ (J − 1) diag (δ)Φdiag (δ)
]
Ws.
Here δ = (δ1, . . . , δT )
′
, and δ̃ is a matrix with the (t, t)th element being δt and the (t, t
′
)th
(t 6= t′) element being δtt′ . Based on the derivation similar to that for sample size (2.3),








s=1 ps (vs − ū)
′
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t=1 δtut (1− ut)
σ
√∑S
s=1 ps (vs − ū)
′
[







where Z is a random variable following the standard normal distribution. For a closed-cohort
SW-CRT, the total number of subjects is jointly determined by the number of clusters (n)
and the number of subjects per cluster (J). Given n, we can calculate the cluster size by
J =
∑S
s=1 ps (vs − ū)
′
δ̃ ◦Ω (vs − ū)− C
nζ20
[∑T









s=1 ps (vs − ū)
′
[diag (δ)Φdiag (δ)] (vs − ū).
2.4. Simulation studies
To investigate the performance of the proposed method, we conducted simulation stud-
ies for SW-CRTs with continuous outcomes. Two cluster sizes were explored: J = 20 and
40. We assumed the subjects to transition to intervention over T = 5 time periods. We
assumed σ2 = 1 and intervention effect ζ0 = 0.2. The time-specific intercepts were specified
as λt = 0.1 (t− 1) for t = 1, . . . , T . For closed-cohort SW-CRTs, we explored two struc-
tures for the within-subject correlation matrix Ω: CS and AR(1). Specifically, under CS
the off-diagonal elements are ρtt′ = ρ1 (t 6= t′) and under AR(1) we specify ρtt′ = ρ|t−t
′|/S
1
(t 6= t′). The between-subject correlation matrix was specified as Φ = 11′ρ2. We explored
(ρ1, ρ2) = {(0.15, 0.03), (0.15, 0.05), (0.30, 0.03), (0.30, 0.05)} to assess the impact of correla-
tions on sample size. Moreover, we investigated different missing patterns, which include
independent missing (IM) and monotone missing (MM). For marginal observed probabilities
10
δ = (δ1, . . . , δT )
′, we consider four sets of observational probabilities:
δ1 = (1.000, 1.000, 1.000, 1.000, 1.000) ,
δ2 = (1.000, 0.790, 0.760, 0.730, 0.700) ,
δ3 = (1.000, 0.925, 0.850, 0.775, 0.700) ,
δ4 = (1.000, 1.000, 1.000, 0.800, 0.700) .
Here δ1 represents the scenario of no missing data, while δ2 , δ3 , δ4 represent scenarios where
an increasing number of subjects miss visits over time with a dropout rate of 0.3 at the end of
study. However, their change patterns are different. Under δ2 the observational probability
drops quickly initially but plateaus afterwards. Under δ3 the observational probability drops
following a linear trend. And under δ4 the observational probability remains high initially but





ρ, as discussed previously. We explored two values for the ICC: ρ = 0.03 and 0.05.
To test the null hypothesis H0 : ζ = 0, we set the two-sided type I error rate α = 0.05 and
power 1− γ = 0.8, respectively, and assumed balanced randomization p1 = · · · = pS = 1/4.
For each combination of design parameters, the simulation scheme is presented as follows:
1. Calculate the required number of clusters (n).
2. Generate a set of observations (Yi) based on simulation parameters under the null
hypothesis H0 : ζ = 0 or alternative hypothesis H1 : ζ = ζ0. Yi is generated from a
multivariate normal random distribution with mean and covariance matrix implied by
the design parameters.
3. Generate missing indicators under different missing patterns and probabilities δ.
4. Calculate β̂ and Σn. The test statistic is Z =
√
n|ζ̂|/σ̂ζ . If Z > z1−α/2, then set
rejection indicator D = 1; otherwise D = 0.
5. Repeat Steps 2-4 for L = 10000 times to obtain Dl for l = 1, . . . , L. The empirical type
I error and empirical power are estimated by
∑L
l=1 Dl/L under the null and alternative
hypothesis, respectively.
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Tables 2.1 and 2.2 present the required number of clusters under different parameter
settings for closed-cohort SW-CRTs with between-subject correlation ρ2 = 0.03 and 0.05,
respectively. We have several observations. First, the comparison between Table 1 and Table
2 shows a drastic change in sample size when ρ2 changes from 0.03 to 0.05. On the other hand,
within each table, sample sizes under ρ1 = 0.15 and ρ1 = 0.30 don’t change as much. This
observation corroborates the theoretical conclusion that between-subject correlation (ρ2)
has a greater impact on sample size than within-subject correlation (ρ1). Second, under the
same between-subject correlation ρ2 (see Table 2.1 or 2.2), the required number of clusters
is influenced by longitudinal correlation structures. For example the first cell in Table 1,
under complete data (δ1), the required number of clusters is 28 for CS structure, but it is
31 for AR(1) structure. Third, the trials with larger cluster size (J) require less number of
clusters. Fourth, the trials with subjects dropping quickly initially (δ2) need larger sample
sizes to compensate the information loss compared to the other missing scenarios (δ3 and
δ4), despite the same dropout rate at the end of study. We also observe that the existence of
various types of correlations mitigates the impact of missing data in SW-CRTs. Specifically,
with a dropout rate of 0.3 at the end of study, the increase in sample size that is needed
to compensate for missing data is at most 19% over the missing patterns considered. Table
2.3 presents the required number of clusters for cross-sectional SW-CRTs. Here we assume
no missing data because each patient only contributes one measurement. Increased ICC (ρ)
leads to increase in required number of clusters, which has been shown in Equation (2.7).
Moreover, larger cluster size leads to less required number of clusters.
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Table 2.1. Required number of clusters (empirical power, empirical type I error) for closed-
cohort SW-CRTs with between-subject correlation ρ2 = 0.03
Missing GEE Adjusted GEE
J Pattern δ ρ1 = 0.15 ρ1 = 0.30 ρ1 = 0.15 ρ1 = 0.30
CS 40 IM δ1 28 (0.8136, 0.0764) 29 (0.8146, 0.0789) 30 (0.8024, 0.0532) 31 (0.7930, 0.0539)
δ2 30 (0.8039, 0.0763) 32 (0.8176, 0.0746) 32 (0.7882, 0.0509) 34 (0.7992, 0.0492)
δ3 29 (0.8092, 0.0812) 30 (0.8099, 0.0716) 31 (0.7944, 0.0499) 32 (0.7951, 0.0508)
δ4 28 (0.8043, 0.0778) 30 (0.8159, 0.0754) 30 (0.7922, 0.0551) 32 (0.8006, 0.0497)
MM δ2 31 (0.8201, 0.0738) 32 (0.8123, 0.0732) 33 (0.8079, 0.0516) 34 (0.7932, 0.0528)
δ3 29 (0.8077, 0.0770) 31 (0.8136, 0.0708) 31 (0.7926, 0.0576) 33 (0.8033, 0.0542)
δ4 28 (0.8120, 0.0710) 30 (0.8275, 0.0788) 30 (0.7918, 0.0556) 32 (0.7975, 0.0530)
20 IM δ1 36 (0.8107, 0.0642) 39 (0.8110, 0.0664) 38 (0.7929, 0.0512) 41 (0.7977, 0.0512)
δ2 41 (0.8043, 0.0668) 44 (0.8064, 0.0634) 43 (0.7887, 0.0516) 46 (0.8062, 0.0492)
δ3 39 (0.8096, 0.0707) 42 (0.8178, 0.0687) 41 (0.7930, 0.0507) 44 (0.7956, 0.0485)
δ4 37 (0.8017, 0.0730) 40 (0.8078, 0.0605) 39 (0.7971, 0.0503) 42 (0.7996, 0.0517)
MM δ2 42 (0.8080, 0.0637) 45 (0.8141, 0.0666) 44 (0.7922, 0.0485) 47 (0.7963, 0.0548)
δ3 40 (0.8160, 0.0688) 42 (0.8111, 0.0664) 42 (0.8079, 0.0533) 44 (0.8038, 0.0544)
δ4 37 (0.8117, 0.0688) 40 (0.8117, 0.0690) 39 (0.7855, 0.0546) 42 (0.7966, 0.0511)
AR(1) 40 IM δ1 31 (0.8097, 0.0737) 32 (0.8114, 0.0716) 33 (0.8074, 0.0541) 34 (0.8009, 0.0541)
δ2 34 (0.8189, 0.0716) 35 (0.8143, 0.0733) 36 (0.8008, 0.0521) 37 (0.8042, 0.0546)
δ3 33 (0.8247, 0.0702) 34 (0.8190, 0.0727) 35 (0.8058, 0.0564) 36 (0.8001, 0.0546)
δ4 32 (0.8147, 0.0749) 33 (0.8135, 0.0790) 34 (0.8054, 0.0549) 35 (0.8059, 0.0560)
MM δ2 35 (0.8174, 0.0703) 36 (0.8189, 0.0761) 37 (0.7941, 0.0516) 38 (0.8005, 0.0524)
δ3 33 (0.8113, 0.0725) 34 (0.8152, 0.0758) 35 (0.7950, 0.0527) 36 (0.7972, 0.0589)
δ4 32 (0.8176, 0.0760) 33 (0.8142, 0.0743) 34 (0.8081, 0.0519) 35 (0.8004, 0.0548)
20 IM δ1 43 (0.8099, 0.0660) 45 (0.8100, 0.0677) 45 (0.8006, 0.0531) 47 (0.7995, 0.0584)
δ2 48 (0.8065, 0.0659) 50 (0.8099, 0.0620) 50 (0.8004, 0.0523) 52 (0.8035, 0.0532)
δ3 46 (0.8082, 0.0676) 48 (0.8064, 0.0599) 48 (0.7980, 0.0557) 50 (0.7984, 0.0529)
δ4 44 (0.8126, 0.0677) 46 (0.8127, 0.0643) 46 (0.7951, 0.0558) 48 (0.7987, 0.0541)
MM δ2 51 (0.8050, 0.0638) 53 (0.8080, 0.0645) 53 (0.8058, 0.0526) 55 (0.8066, 0.0516)
δ3 47 (0.8060, 0.0621) 49 (0.8117, 0.0604) 49 (0.8112, 0.0522) 51 (0.8005, 0.0506)
δ4 44 (0.8023, 0.0658) 46 (0.8095, 0.0689) 46 (0.8014, 0.0580) 48 (0.8076, 0.0552)
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Table 2.2. Required number of clusters (empirical power, empirical type I error) for closed-
cohort SW-CRTs with between-subject correlation ρ2 = 0.05
Missing GEE Adjusted GEE
J Pattern δ ρ1 = 0.15 ρ1 = 0.30 ρ1 = 0.15 ρ1 = 0.30
CS 40 IM δ1 40 (0.8112, 0.0724) 41 (0.8069, 0.0659) 42 (0.7939, 0.0532) 43 (0.7879, 0.0553)
δ2 43 (0.8162, 0.0684) 44 (0.8141, 0.0663) 45 (0.8024, 0.0509) 46 (0.7983, 0.0497)
δ3 42 (0.8163, 0.0680) 43 (0.8136, 0.0666) 44 (0.8060, 0.0534) 45 (0.8004, 0.0561)
δ4 41 (0.8197, 0.0695) 42 (0.8120, 0.0682) 43 (0.7956, 0.0484) 44 (0.8077, 0.0490)
MM δ2 43 (0.8064, 0.0678) 44 (0.8075, 0.0607) 45 (0.7997, 0.0564) 46 (0.7871, 0.0505)
δ3 42 (0.8105, 0.0678) 43 (0.8097, 0.0680) 44 (0.8023, 0.0514) 45 (0.8051, 0.0549)
δ4 41 (0.8164, 0.0716) 42 (0.8042, 0.0699) 43 (0.7999, 0.0530) 44 (0.7964, 0.0578)
20 IM δ1 48 (0.8112, 0.0658) 51 (0.8113, 0.0660) 50 (0.7965, 0.0521) 53 (0.7992, 0.0521)
δ2 53 (0.8085, 0.0623) 56 (0.8062, 0.0653) 55 (0.8015, 0.0506) 58 (0.7978, 0.0536)
δ3 51 (0.8040, 0.0657) 54 (0.8060, 0.0647) 53 (0.8016, 0.0530) 56 (0.8112, 0.0511)
δ4 49 (0.8057, 0.0661) 52 (0.8092, 0.0676) 51 (0.7919, 0.0516) 54 (0.8019, 0.0572)
MM δ2 54 (0.8071, 0.0666) 57 (0.8037, 0.0611) 56 (0.7970, 0.0570) 59 (0.7946, 0.0509)
δ3 51 (0.8097, 0.0668) 54 (0.8109, 0.0608) 53 (0.7926, 0.0525) 56 (0.8013, 0.0525)
δ4 49 (0.8078, 0.0647) 52 (0.8050, 0.0596) 51 (0.7935, 0.0511) 54 (0.8033, 0.0553)
AR(1) 40 IM δ1 43 (0.7994, 0.0671) 44 (0.8086, 0.0683) 45 (0.8007, 0.0574) 46 (0.7973, 0.0579)
δ2 46 (0.8070, 0.0649) 47 (0.8139, 0.0681) 48 (0.7979, 0.0533) 49 (0.7982, 0.0553)
δ3 45 (0.8062, 0.0658) 46 (0.8099, 0.0662) 47 (0.7983, 0.0527) 48 (0.8053, 0.0525)
δ4 44 (0.8086, 0.0612) 45 (0.8125, 0.0622) 46 (0.8041, 0.0511) 47 (0.8127, 0.0580)
MM δ2 47 (0.8056, 0.0668) 49 (0.8110, 0.0674) 49 (0.8015, 0.0556) 51 (0.8063, 0.0566)
δ3 45 (0.8024, 0.0668) 47 (0.8107, 0.0684) 47 (0.8006, 0.0546) 49 (0.8079, 0.0564)
δ4 44 (0.8078, 0.0663) 45 (0.8105, 0.0673) 46 (0.8052, 0.0528) 47 (0.8043, 0.0545)
20 IM δ1 55 (0.8159, 0.0631) 57 (0.8154, 0.0668) 57 (0.8056, 0.0552) 59 (0.7952, 0.0567)
δ2 60 (0.8063, 0.0620) 62 (0.8067, 0.0647) 62 (0.8064, 0.0520) 64 (0.8014, 0.0525)
δ3 58 (0.8057, 0.0659) 60 (0.8064, 0.0651) 60 (0.8018, 0.0516) 62 (0.7981, 0.0543)
δ4 56 (0.8057, 0.0631) 58 (0.8080, 0.0611) 58 (0.7978, 0.0507) 60 (0.8003, 0.0513)
MM δ2 63 (0.8192, 0.0570) 65 (0.8061, 0.0617) 65 (0.8011, 0.0531) 67 (0.8025, 0.0530)
δ3 59 (0.8074, 0.0625) 61 (0.8039, 0.0602) 61 (0.8051, 0.0550) 63 (0.7951, 0.0529)
δ4 56 (0.8001, 0.0640) 58 (0.8061, 0.0599) 58 (0.8003, 0.0522) 60 (0.7997, 0.0495)
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Table 2.3. Required number of clusters (empirical power, empirical type I error) for cross-
sectional SW-CRTs
GEE Adjusted GEE
J ρ = 0.03 ρ = 0.05 ρ = 0.03 ρ = 0.05
40 27 (0.8132, 0.0796) 39 (0.8006, 0.0745) 29 (0.7979, 0.0522) 41 (0.7911, 0.0526)
20 35 (0.8158, 0.0703) 47 (0.8075, 0.0634) 37 (0.8000, 0.0495) 49 (0.8026, 0.0491)
The proposed method was developed based on the GEE approach, which requires the
large sample theory to ensure the validity of statistical inference. When the number of clus-
ters is small, even if the total number of unique patients is large, the variance of treatment
effect can be underestimated, which leads to inflated type I error rate. To adjust for the esti-
mation bias under small numbers of clusters, researchers have proposed many methods, such
as making correction on the GEE variance estimator (Mancl and DeRouen, 2001; Kauermann
and Carroll, 2001; Ziegler and Vens, 2010; Morel et al., 2003), making inferences based on
t-distribution or F-distribution, or combination of different adjustment methods (Fay and
Graubard, 2001; Pan and Wall, 2002; McCaffrey and Bell, 2006; Fan et al., 2013). The first
two columns of Tables 2.1-2.3 show results based on GEE approach without correction. We
observe that the empirical powers and type I errors are both inflated, a typical symptom
of underestimated variance. We explored various adjustment methods and found that the
combination of Morel et al. (2003) (MBN) and Donner and Klar (2000) offers a good balance
between easy implementation and maintaining the power and type I error at nominal lev-
els. Specifically, the MBN method adds a correction term to the GEE covariance estimator.
This correction term converges to zero as the number of clusters increases. Donner and Klar
(2000) suggested adding one cluster per intervention when the sample size is determined
under 0.05 type I error. Simulation results based on the adjusted GEE are presented in the
last two columns of Tables 2.1-2.3, which show that after correction, the empirical powers
and type I errors are close to the nominal levels of 0.8 and 0.05, respectively.
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2.5. A real application example
We illustrate the proposed method in the determination of sample size for a SW-CRT
evaluating the effect of a physician training program (in interpersonal and communication
skills) on female patients’ satisfaction with doctor-women relationship in labor and delivery
rooms (Bashour et al., 2013). The primary outcome is defined as the total score over a series
of questions on a Likert scale modified from the Medical Interview Satisfaction Scale. The
data will be collected T = 5 times evenly over a 10-month follow-up period. Preliminary
data indicates that the mean of the satisfaction score is 3.23 (SD 0.72) in the control group




for s = 1, . . . , 4. We would like to detect a difference of 0.2 in mean satisfaction
score with 80% power at a two-sided significance level of 0.05. For a closed-cohort SW-CRT
where the within-subject correlation is CS with ρ1 = 0.15 and between-subject correlation
is Φ = 11
′
ρ2 with ρ2 = 0.03, the required numbers of clusters are 36 and 40 for complete
data and missing data with δ = (1.00, 0.85, 0.80, 0.75, 0.70) under IM missing pattern,
respectively when cluster size is 20. If cluster size is 50, the required numbers of clusters
are 26 and 28, respectively. For a cross-sectional SW-CRT with ICC ρ = 0.03, the required
numbers of clusters are 35 and 25 when cluster size is 20 and 50, respectively.
2.6. Extension to outcomes from the exponential family
Besides continuous outcomes, binary and count patient-centered outcomes are often en-
countered in clinical trials. For those types of outcomes, binomial and Poisson models can
be employed. A similar sample size derivation approach based on GEE can be implemented
because they all belong to the exponential family. The procedure for outcomes from the
exponential family is developed as follows. Suppose Yijt follows a distribution from an ex-
ponential family with mean µij = E (Yij) and a link function g(µij), we have
g (µij) = λ+ uiζ = Xiβ.
16
















The variance of Yij is shown in Table 2.4.
Assuming an independent working correlation structure, the GEE estimator of β is ob-




























with µij (β) = g
−1 (Xiβ).
Under mild regularity conditions, as n → ∞, √n(β̂ − β) → N (0, Σn) in distribution.
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for a vector c.














sGs [Ω + (J − 1)Φ]GsWs, (2.11)
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where Ws = (IT ,vs). Bs and Gs are shown in Table 2.4. The derivation is shown in
Appendix. To reject the null hypothesis H0 : ζ = 0 with a power 1− γ at a significance level







where ζ0 is the true intervention effect and σ
2
ζ is the (T + 1, T + 1)-component of Σ.
If missing data is considered with missing indicator ∆ijt, Under the assumption of missing





































δ̃ ◦GsΩGs + (J − 1) diag (δ)GsΦGsdiag (δ)
]
Ws
where δ = (δ1, . . . , δT )
′
, δ̃ is a matrix with diagonal (t, t)th element being δt and off-diagonal
(t, t
′








where σ2ζ is the (T + 1, T + 1)-component of A
∗−1E∗A∗−1.
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Table 2.4. Notations for different types of outcome
Continuous Binary Count
Distribution Normal Bernoulli Poisson









































































µst is the mean of outcomes from sth sequence at tth time point.
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We conducted simulation studies for closed-cohort and cross-sectional SW-CRTs with
binary and count outcomes. Suppose subjects were transited into intervention over T = 4
time points and cluster size was J = 15. For binary outcomes, we set time-specific intercepts
λt = 0.01 (t− 1) for t = 1, . . . , T and ζ = {log(1.5), log(1.8)} corresponding to odds ratio 1.5
and 1.8, respectively. For count outcomes, we set time-specific intercepts λt = 1+0.3 (t− 1)
for t = 1, . . . , T and ζ = {0.10, 0.13}. For closed-cohort SW-CRTs, we explored CS and
AR(1) structures for within-subject correlation matrix Ω and Φ = 11′ρ2 for between-subject
correlation matrix. We also explored (ρ1, ρ2) = {(0.2, 0.03), (0.2, 0.05), (0.4, 0.03), (0.4, 0.05)}
to assess the impact of correlations on sample size. Moreover, we investigated different
missing patterns with independent missing (IM) and monotone missing (MM), as well as
four sets of observational probabilities:
δ1 = (1.00, 1.00, 1.00, 1.00) ,
δ2 = (1.00, 0.80, 0.75, 0.70) ,
δ3 = (1.00, 0.90, 0.80, 0.70) ,
δ4 = (1.00, 1.00, 0.85, 0.70) .
For cross-sectional SW-CRTs, we specified Ω = 11
′
ρ + (1 − ρ)I and Φ = 11′ρ, as was
discussed in SW-CRTs with continuous outcomes. We explored two values for the ICC:
ρ = 0.03 and 0.05. To test the null hypothesis H0 : ζ = 0, we set the two-sided type I error
rate α = 0.05 and power 1 − γ = 0.8, respectively, and assumed balanced randomization
p1 = · · · = pS = 1/3.
Tables 2.5-2.6 and Tables 2.8-2.9 present the required number of clusters with empirical
power and type I error for closed-cohort SW-CRTs with binary and count outcomes, respec-
tively. We have several observations. First, more clusters are required when between-subject
correlation and longitudinal correlation get larger. For example, the first row in Table 2.5,
the required number of clusters changes from 51 to 54 when longitudinal correlation (ρ1)
increases from 0.2 to 0.4, respectively. On the other hand, the first cells in Tables 2.5-2.6,
the required number of clusters increases from 51 to 63 when between-subject correlation
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(ρ2) increases from 0.03 to 0.05. Second, the longitudinal correlation structures affect the
required number of clusters, which can be shown by comparing the first and second pan-
els in each table for closed-cohort SW-CRTs. Third, larger ζ leads to smaller sample size,
which can be easily proofed theoretically. Fourth, different missing patterns and observa-
tional probabilities affect the required number of clusters. The missing scenario with subjects
dropping quickly initially (δ2) requires more additional clusters to achieve the desired power.
On the other hand, the scenario with subjects dropping quickly near the end of the trial (δ4)
requires less additional clusters to compensate the loss due to missing compared to the other
missing scenarios with the same dropout rate at the end of the study. Tables 2.7 and 2.10
present the required number of clusters with empirical power and type I error for cross-
sectional SW-CRTs with binary and count outcomes, respectively. Similar to observations
from closed-cohort SW-CRTs, the larger ζ and smaller correlations lead to smaller required
number of clusters.
The last two columns in Tables 2.5-2.10 show the empirical powers and type I errors
after adjustment using the combination of MBN and Donner and Klar’s method as described
previously in SW-CRTs with continuous outcomes. The results show that after adjustment,
the empirical powers and type I errors are very close to their nominal values, which are 0.8
and 0.05, respectively. For example, in Table 2.5 when required number of clusters is less
than 30, the inflated type I error is larger than 0.07. After adjustment, the type I error drops
to around 0.05. Therefore, this proposed combination method for adjusting inflated type I
error works very well in SW-CRTs not only for continuous outcomes, but also for binary and
count outcomes.
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Table 2.5. Required number of clusters (empirical power, empirical type I error) for binary
outcomes with between-subject correlation ρ2 = 0.03
Missing GEE Adjusted GEE
ζ Pattern δ ρ1 = 0.2 ρ1 = 0.4 ρ1 = 0.2 ρ1 = 0.4
CS log(1.5) IM δ1 51 (0.7998, 0.0587) 54 (0.8063, 0.0576) 53 (0.7920, 0.0518) 56 (0.8007, 0.0479)
δ2 60 (0.8030, 0.0566) 63 (0.8140, 0.0581) 62 (0.8050, 0.0499) 65 (0.8061, 0.0483)
δ3 56 (0.8014, 0.0615) 59 (0.8046, 0.0664) 58 (0.8019, 0.0494) 61 (0.7959, 0.0489)
δ4 54 (0.8124, 0.0596) 56 (0.8003, 0.0636) 56 (0.8004, 0.0504) 58 (0.7978, 0.0534)
MM δ2 60 (0.8110, 0.0643) 64 (0.7993, 0.0601) 62 (0.8013, 0.0549) 66 (0.7993, 0.0496)
δ3 57 (0.8073, 0.0616) 60 (0.8074, 0.0595) 59 (0.8047, 0.0497) 62 (0.8026, 0.0515)
δ4 54 (0.8167, 0.0596) 56 (0.8075, 0.0642) 56 (0.8072, 0.0494) 58 (0.7961, 0.0520)
log(1.8) IM δ1 25 (0.8165, 0.0737) 27 (0.8233, 0.0745) 27 (0.7979, 0.0498) 29 (0.8052, 0.0525)
δ2 29 (0.8108, 0.0757) 31 (0.8127, 0.0734) 31 (0.7928, 0.0497) 33 (0.8042, 0.0546)
δ3 28 (0.8189, 0.0732) 29 (0.8095, 0.0703) 30 (0.8020, 0.0480) 31 (0.7952, 0.0496)
δ4 26 (0.8124, 0.0758) 28 (0.8144, 0.0755) 28 (0.7971, 0.0474) 30 (0.8074, 0.0525)
MM δ2 30 (0.8244, 0.0716) 31 (0.8137, 0.0704) 32 (0.8107, 0.0499) 33 (0.7991, 0.0491)
δ3 28 (0.8180, 0.0737) 29 (0.8180, 0.0713) 30 (0.7976, 0.0491) 31 (0.7983, 0.0515)
δ4 26 (0.8062, 0.0748) 28 (0.8189, 0.0740) 28 (0.7925, 0.0514) 30 (0.8063, 0.0511)
AR(1) log(1.5) IM δ1 57 (0.8104, 0.0567) 59 (0.8019, 0.0611) 59 (0.7993, 0.0517) 61 (0.8102, 0.0505)
δ2 65 (0.8055, 0.0610) 68 (0.8038, 0.0602) 67 (0.8008, 0.0506) 70 (0.8028, 0.0555)
δ3 62 (0.8128, 0.0606) 64 (0.7968, 0.0604) 64 (0.8014, 0.0550) 66 (0.8017, 0.0483)
δ4 59 (0.8023, 0.0629) 61 (0.8092, 0.0608) 61 (0.7988, 0.0518) 63 (0.7945, 0.0520)
MM δ2 67 (0.8032, 0.0587) 70 (0.8093, 0.0606) 69 (0.7985, 0.0494) 72 (0.7996, 0.0467)
δ3 63 (0.8147, 0.0619) 65 (0.8027, 0.0614) 65 (0.8029, 0.0544) 67 (0.7977, 0.0513)
δ4 59 (0.8015, 0.0606) 61 (0.8007, 0.0637) 61 (0.7983, 0.0494) 63 (0.7901, 0.0528)
log(1.8) IM δ1 28 (0.8145, 0.0720) 29 (0.8129, 0.0723) 30 (0.8061, 0.0507) 31 (0.8038, 0.0524)
δ2 32 (0.8227, 0.0720) 33 (0.8185, 0.0704) 34 (0.8015, 0.0508) 35 (0.8043, 0.0513)
δ3 30 (0.8104, 0.0732) 32 (0.8247, 0.0714) 32 (0.7948, 0.0495) 34 (0.8107, 0.0490)
δ4 29 (0.8086, 0.0779) 30 (0.8111, 0.0661) 31 (0.7925, 0.0495) 32 (0.8018, 0.0541)
MM δ2 33 (0.8173, 0.0692) 34 (0.8077, 0.0715) 35 (0.7963, 0.0486) 36 (0.8042, 0.0534)
δ3 31 (0.8157, 0.0731) 32 (0.8108, 0.0772) 33 (0.8090, 0.0521) 34 (0.8013, 0.0567)
δ4 29 (0.8182, 0.0762) 30 (0.8067, 0.0765) 31 (0.7985, 0.0540) 32 (0.8033, 0.0562)
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Table 2.6. Required number of clusters (empirical power, empirical type I error) for binary
outcomes with between-subject correlation ρ2 = 0.05
Missing GEE Adjusted GEE
ζ Pattern δ ρ1 = 0.2 ρ1 = 0.4 ρ1 = 0.2 ρ1 = 0.4
CS log(1.5) IM δ1 63 (0.8003, 0.0638) 66 (0.8033, 0.0576) 65 (0.7973, 0.0513) 68 (0.7923, 0.0502)
δ2 72 (0.8039, 0.0571) 75 (0.8082, 0.0598) 74 (0.8043, 0.0486) 77 (0.8079, 0.0486)
δ3 69 (0.8086, 0.0582) 72 (0.8051, 0.0578) 71 (0.8039, 0.0527) 74 (0.8078, 0.0523)
δ4 66 (0.8004, 0.0625) 69 (0.8064, 0.0563) 68 (0.7984, 0.0499) 71 (0.7979, 0.0490)
MM δ2 73 (0.8109, 0.0613) 76 (0.8083, 0.0583) 75 (0.8074, 0.0565) 78 (0.8001, 0.0500)
δ3 69 (0.8048, 0.0590) 72 (0.8038, 0.0609) 71 (0.7981, 0.0505) 74 (0.7958, 0.0462)
δ4 66 (0.8045, 0.0634) 69 (0.8079, 0.0631) 68 (0.7950, 0.0536) 71 (0.8035, 0.0547)
log(1.8) IM δ1 31 (0.8105, 0.0680) 33 (0.8210, 0.0708) 33 (0.7973, 0.0534) 35 (0.8059, 0.0504)
δ2 35 (0.8173, 0.0695) 37 (0.8164, 0.0665) 37 (0.7972, 0.0462) 39 (0.8092, 0.0521)
δ3 34 (0.8097, 0.0667) 35 (0.8144, 0.0711) 36 (0.8081, 0.0496) 37 (0.7919, 0.0517)
δ4 32 (0.8140, 0.0717) 34 (0.8145, 0.0693) 34 (0.8019, 0.0542) 36 (0.8008, 0.0549)
MM δ2 36 (0.8233, 0.0687) 37 (0.8055, 0.0688) 38 (0.8064, 0.0515) 39 (0.7922, 0.0504)
δ3 34 (0.8105, 0.0753) 35 (0.8061, 0.0661) 36 (0.8023, 0.0543) 37 (0.7991, 0.0527)
δ4 32 (0.8075, 0.0703) 34 (0.8110, 0.0710) 34 (0.7917, 0.0516) 36 (0.8011, 0.0533)
AR(1) log(1.5) IM δ1 69 (0.8043, 0.0599) 71 (0.8022, 0.0569) 71 (0.7966, 0.0502) 73 (0.7955, 0.0484)
δ2 78 (0.8087, 0.0572) 80 (0.8042, 0.0536) 80 (0.8002, 0.0465) 82 (0.7966, 0.0502)
δ3 74 (0.8056, 0.0552) 77 (0.8091, 0.0549) 76 (0.8028, 0.0485) 79 (0.8049, 0.0502)
δ4 72 (0.8010, 0.0591) 74 (0.8047, 0.0575) 74 (0.8056, 0.0535) 76 (0.8058, 0.0492)
MM δ2 80 (0.8107, 0.0596) 83 (0.8071, 0.0551) 82 (0.8008, 0.0523) 85 (0.8080, 0.0515)
δ3 75 (0.8090, 0.0621) 78 (0.8104, 0.0548) 77 (0.8020, 0.0508) 80 (0.7993, 0.0507)
δ4 72 (0.7978, 0.0604) 74 (0.8116, 0.0543) 74 (0.7998, 0.0499) 76 (0.8046, 0.0506)
log(1.8) IM δ1 34 (0.8130, 0.0697) 35 (0.8111, 0.0732) 36 (0.8052, 0.0536) 37 (0.7972, 0.0556)
δ2 38 (0.8156, 0.0622) 39 (0.8186, 0.0687) 40 (0.8014, 0.0511) 41 (0.8047, 0.0490)
δ3 36 (0.8094, 0.0699) 38 (0.8201, 0.0713) 38 (0.7907, 0.0520) 40 (0.8030, 0.0564)
δ4 35 (0.8130, 0.0711) 36 (0.8066, 0.0686) 37 (0.8021, 0.0528) 38 (0.8022, 0.0512)
MM δ2 39 (0.8137, 0.0661) 40 (0.8072, 0.0641) 41 (0.8005, 0.0536) 42 (0.8047, 0.0531)
δ3 37 (0.8182, 0.0670) 38 (0.8077, 0.0677) 39 (0.7950, 0.0540) 40 (0.8041, 0.0570)
δ4 35 (0.8100, 0.0678) 36 (0.8205, 0.0681) 37 (0.7941, 0.0542) 38 (0.7980, 0.0522)
Table 2.7. Required number of clusters (empirical power, empirical type I error) for cross-
sectional SW-CRTs with binary outcomes
GEE Adjusted GEE
ζ ρ = 0.03 ρ = 0.05 ρ = 0.03 ρ = 0.05
log(1.5) 49 (0.8077, 0.0600) 61 (0.8116, 0.0616) 51 (0.7935, 0.0495) 63 (0.7919, 0.0543)
log(1.8) 24 (0.8091, 0.0850) 30 (0.8136, 0.0781) 26 (0.7948, 0.0492) 32 (0.8001, 0.0511)
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Table 2.8. Required number of clusters (empirical power, empirical type I error) for count
outcomes with between-subject correlation ρ2 = 0.03
Missing GEE Adjusted GEE
ζ Pattern δ ρ1 = 0.2 ρ1 = 0.4 ρ1 = 0.2 ρ1 = 0.4
CS 0.10 IM δ1 46 (0.8191, 0.0668) 48 (0.8176, 0.0662) 48 (0.8149, 0.0525) 50 (0.8037, 0.0541)
δ2 53 (0.8105, 0.0661) 56 (0.8150, 0.0640) 55 (0.8049, 0.0541) 58 (0.8033, 0.0534)
δ3 51 (0.8169, 0.0570) 53 (0.8079, 0.0625) 53 (0.8049, 0.0537) 55 (0.7958, 0.0546)
δ4 48 (0.8082, 0.0644) 51 (0.8136, 0.0640) 50 (0.8044, 0.0526) 53 (0.8087, 0.0544)
MM δ2 54 (0.8104, 0.0650) 57 (0.8059, 0.0621) 56 (0.8023, 0.0498) 59 (0.8005, 0.0493)
δ3 51 (0.8209, 0.0607) 54 (0.8149, 0.0623) 53 (0.8101, 0.0523) 56 (0.8001, 0.0506)
δ4 48 (0.8037, 0.0658) 51 (0.8120, 0.0577) 50 (0.7980, 0.0521) 53 (0.8103, 0.0524)
0.13 IM δ1 27 (0.8215, 0.0792) 28 (0.8145, 0.0781) 29 (0.8053, 0.0524) 30 (0.8030, 0.0545)
δ2 31 (0.8064, 0.0692) 33 (0.8198, 0.0735) 33 (0.7981, 0.0535) 35 (0.8092, 0.0537)
δ3 30 (0.8155, 0.0746) 31 (0.8119, 0.0775) 32 (0.8040, 0.0505) 33 (0.7960, 0.0563)
δ4 28 (0.8188, 0.0750) 30 (0.8182, 0.0739) 30 (0.7974, 0.0492) 32 (0.8097, 0.0504)
MM δ2 32 (0.8224, 0.0700) 34 (0.8201, 0.0766) 34 (0.8052, 0.0547) 36 (0.8126, 0.0516)
δ3 30 (0.8118, 0.0791) 32 (0.8255, 0.0708) 32 (0.7969, 0.0534) 34 (0.8064, 0.0534)
δ4 28 (0.8212, 0.0738) 30 (0.8244, 0.0782) 30 (0.7975, 0.0540) 32 (0.8078, 0.0516)
AR(1) 0.10 IM δ1 51 (0.8143, 0.0597) 52 (0.8140, 0.0639) 53 (0.8069, 0.0512) 54 (0.7973, 0.0470)
δ2 58 (0.8147, 0.0610) 60 (0.8134, 0.0569) 60 (0.8030, 0.0525) 62 (0.8020, 0.0530)
δ3 56 (0.8097, 0.0605) 58 (0.8139, 0.0611) 58 (0.8092, 0.0519) 60 (0.8043, 0.0535)
δ4 53 (0.8134, 0.0627) 55 (0.8131, 0.0639) 55 (0.8101, 0.0529) 57 (0.8002, 0.0518)
MM δ2 60 (0.8156, 0.0632) 63 (0.8122, 0.0590) 62 (0.8103, 0.0502) 65 (0.8067, 0.0515)
δ3 56 (0.8135, 0.0595) 59 (0.8099, 0.0632) 58 (0.8015, 0.0562) 61 (0.8094, 0.0534)
δ4 53 (0.8116, 0.0627) 55 (0.8066, 0.0627) 55 (0.7982, 0.0543) 57 (0.8058, 0.0521)
0.13 IM δ1 30 (0.8235, 0.0762) 31 (0.8153, 0.0689) 32 (0.8156, 0.0541) 33 (0.8084, 0.0544)
δ2 34 (0.8139, 0.0688) 35 (0.8125, 0.0713) 36 (0.8000, 0.0517) 37 (0.7992, 0.0512)
δ3 33 (0.8194, 0.0761) 34 (0.8177, 0.0725) 35 (0.8131, 0.0571) 36 (0.8074, 0.0536)
δ4 31 (0.8116, 0.0747) 32 (0.8169, 0.0764) 33 (0.7966, 0.0527) 34 (0.7969, 0.0528)
MM δ2 35 (0.8207, 0.0721) 37 (0.8230, 0.0714) 37 (0.8022, 0.0516) 39 (0.8155, 0.0504)
δ3 33 (0.8165, 0.0707) 34 (0.8116, 0.0736) 35 (0.7996, 0.0554) 36 (0.8035, 0.0591)
δ4 31 (0.8137, 0.0750) 32 (0.8149, 0.0722) 33 (0.7980, 0.0549) 34 (0.7974, 0.0533)
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Table 2.9. Required number of clusters (empirical power, empirical type I error) for count
outcomes with between-subject correlation ρ2 = 0.05
Missing GEE Adjusted GEE
ζ Pattern δ ρ1 = 0.2 ρ1 = 0.4 ρ1 = 0.2 ρ1 = 0.4
CS 0.10 IM δ1 56 (0.8113, 0.0623) 59 (0.8062, 0.0632) 58 (0.8014, 0.0524) 61 (0.8105, 0.0515)
δ2 64 (0.8063, 0.0602) 67 (0.8141, 0.0611) 66 (0.8096, 0.0574) 69 (0.8094, 0.0528)
δ3 61 (0.8064, 0.0605) 64 (0.8121, 0.0606) 63 (0.8020, 0.0498) 66 (0.8116, 0.0511)
δ4 59 (0.8105, 0.0604) 62 (0.8083, 0.0595) 61 (0.8115, 0.0549) 64 (0.8091, 0.0528)
MM δ2 65 (0.8194, 0.0604) 68 (0.8219, 0.0589) 67 (0.8061, 0.0523) 70 (0.8118, 0.0561)
δ3 62 (0.8149, 0.0616) 65 (0.8123, 0.0626) 64 (0.8068, 0.0532) 67 (0.8058, 0.0511)
δ4 59 (0.8111, 0.0625) 62 (0.8114, 0.0630) 61 (0.8103, 0.0540) 64 (0.7954, 0.0536)
0.13 IM δ1 33 (0.8172, 0.0695) 35 (0.8224, 0.0698) 35 (0.8055, 0.0516) 37 (0.8117, 0.0553)
δ2 38 (0.8209, 0.0710) 39 (0.8188, 0.0659) 40 (0.8060, 0.0526) 41 (0.8098, 0.0515)
δ3 36 (0.8121, 0.0673) 38 (0.8174, 0.0684) 38 (0.8045, 0.0500) 40 (0.8119, 0.0529)
δ4 35 (0.8250, 0.0691) 36 (0.8105, 0.0753) 37 (0.8045, 0.0522) 38 (0.8008, 0.0552)
MM δ2 38 (0.8191, 0.0683) 40 (0.8115, 0.0695) 40 (0.7995, 0.0507) 42 (0.8105, 0.0534)
δ3 36 (0.8159, 0.0697) 38 (0.8222, 0.0694) 38 (0.8070, 0.0510) 40 (0.8119, 0.0528)
δ4 35 (0.8178, 0.0725) 36 (0.8161, 0.0696) 37 (0.8081, 0.0493) 38 (0.7968, 0.0526)
AR(1) 0.10 IM δ1 61 (0.8138, 0.0586) 63 (0.8068, 0.0609) 63 (0.7991, 0.0531) 65 (0.8164, 0.0486)
δ2 69 (0.8119, 0.0590) 71 (0.8013, 0.0595) 71 (0.8008, 0.0500) 73 (0.8005, 0.0513)
δ3 67 (0.8114, 0.0635) 69 (0.8146, 0.0646) 69 (0.8113, 0.0539) 71 (0.8153, 0.0509)
δ4 64 (0.8126, 0.0606) 66 (0.8083, 0.0590) 66 (0.8078, 0.0498) 68 (0.8099, 0.0514)
MM δ2 71 (0.8101, 0.0619) 74 (0.8187, 0.0596) 73 (0.8076, 0.0498) 76 (0.8220, 0.0547)
δ3 67 (0.8095, 0.0526) 70 (0.8169, 0.0595) 69 (0.8050, 0.0483) 72 (0.8166, 0.0555)
δ4 64 (0.8192, 0.0581) 66 (0.8138, 0.0655) 66 (0.8068, 0.0524) 68 (0.8044, 0.0520)
0.13 IM δ1 36 (0.8251, 0.0699) 37 (0.8132, 0.0709) 38 (0.8059, 0.0557) 39 (0.8079, 0.0531)
δ2 41 (0.8202, 0.0667) 42 (0.8190, 0.0685) 43 (0.8052, 0.0536) 44 (0.8026, 0.0523)
δ3 39 (0.8184, 0.0668) 40 (0.8116, 0.0746) 41 (0.8063, 0.0530) 42 (0.8047, 0.0572)
δ4 38 (0.8232, 0.0667) 39 (0.8095, 0.0684) 40 (0.8114, 0.0541) 41 (0.8109, 0.0547)
MM δ2 42 (0.8145, 0.0692) 43 (0.8164, 0.0672) 44 (0.8117, 0.0528) 45 (0.8016, 0.0542)
δ3 40 (0.8157, 0.0696) 41 (0.8160, 0.0725) 42 (0.8160, 0.0509) 43 (0.8102, 0.0498)
δ4 38 (0.8147, 0.0672) 39 (0.8133, 0.0699) 40 (0.8128, 0.0519) 41 (0.8073, 0.0532)
Table 2.10. Required number of clusters (empirical power, empirical type I error) for cross-
sectional SW-CRTs with count outcomes
GEE Adjusted GEE
ζ ρ = 0.03 ρ = 0.05 ρ = 0.03 ρ = 0.05
0.10 43 (0.8091, 0.0688) 55 (0.8149, 0.0598) 45 (0.8005, 0.0506) 57 (0.8013, 0.0483)
0.13 26 (0.8316, 0.0756) 32 (0.8209, 0.0741) 28 (0.8035, 0.0510) 34 (0.7984, 0.0534)
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2.7. Discussion
In this study we present closed-form sample size formulas for closed-cohort and cross-
sectional SW-CRTs with outcomes from the exponential family. The sample sizes are derived
based on the GEE approach, which is flexible in accommodating arbitrary structures of lon-
gitudinal and between-subject correlations through the specification of Ω and Φ. Moreover,
through the specification of missing data pattern as well as marginal and joint observational
probabilities, the proposed sample size method offers great flexibility in accounting for miss-
ing data. Due to the prolonged follow-up, the problem of missing data tends to be more
pronounced in SW-CRTs than in traditional CRTs. By introducing vs and ps, the proposed
sample sizes also accommodate arbitrary crossover schemes. For example, unbalanced ran-
domization is accommodated by unequal ps (s = 1, · · · , S), while setting ps = 0 represents
an irregular crossover scheme where no cluster switch to intervention at Step s+ 1.
The closed-form formula for SW-CRTs with continuous outcomes shows that the time-
specific intercepts do not affect the required number of clusters, which is consistent with the
results in Li et al. (2018). However, it affects the required number of clusters in SW-CRTs
with binary and count outcomes. Moreover, the closed-form formulas for SW-CRTs with
continuous outcomes enable us to theoretically show that under T = 3 steps, the within-
subject (longitudinal) correlation has no impact on sample size, and that under T = 4
steps, as long as the correlation between measurements at Time 2 and 3 are equal, different
longitudinal correlation structures (such as CS and AR(1)) will lead to the same sample size
requirement. Simulation results demonstrate that the proposed sample size method and the
adjustment method perform well in maintaining the nominal power and type I error under a




A BAYESIAN ADAPTIVE DESIGN FOR SW-CRTS
3.1. Introduction
Adaptive designs have been increasingly considered for years in clinical research and de-
velopment due to their flexibility and efficiency based on the accumulated data (Montaner
et al., 1990; Rosenberger et al., 2001; Jennison and Turnbull, 2005). Specifically, they enable
researchers to modify the design for determining the optimal intervention under investigation
based on the review of interim data without destroying the validity and integrity of their
intended studies (Chow et al., 2005). One of the popular adaptive designs is the group se-
quential design that attracted much attention in clinical trials. For example, Reiertsen et al.
(1997) conducted a group sequential design to compare the diagnostic and therapeutic la-
paroscopy with conventional appedicectomy. Vahedi et al. (2007) did a group sequential trial
for assessment of the efficacy of early decompressive craniectomy in patients with malignant
middle cerebral artery infarction. The purpose of group sequential design is to shorten the
length of clinical trials in a more efficient way without compromising the treatment safety
and efficacy by maximizing the power for identifying the optimal intervention. Specifically,
group sequential design employs stopping rules that will allow researchers to make a decision
regarding whether to stop the trial early in case of overwhelming efficacy or futility based on
the results of interim analysis. In other words, flexibility can be increased, as well as patient
exposure, cost, and trial duration can be reduced if the intervention has been tested either
exceedingly good or exceedingly poor.
Group sequential design with Bayesian approach is called Bayesian group sequential
design, which has been investigated by many researchers (Heitjan, 1997; Zhou et al., 2008;
Lee et al., 2010; Zhu and Yu, 2017). It can stop the trial early due to efficacy or futility as
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that in frequentist group sequential designs, but with its own advantages: (1) it provides a
natural way to make statistical inferences by combining information from the observed data
and previous studies; (2) it obeys the likelihood principle without constrained by the design
and doesn’t require large sample theory for valid inference; (3) it gives interpretable results
through a decision theoretical framework (Carlin and Louis, 2008; Gelman et al., 2013).
Stepped wedge cluster randomized trial (SW-CRT) is a relatively new trial that is fre-
quently adopted to overcome the limitations of the traditional cluster randomized trials on
practical considerations, such as large-scale research studies, availability of resources, ethical
considerations, and cost-effectiveness. There are two popular frequentist statistical analysis
methods for SW-CRTs, which are generalized linear mixed model and generalized estimating
equations (Barker et al., 2016). Beside frequentist methods, recently the Bayesian approach
has been implemented for SW-CRTs in several applications. For example, Reuther et al.
(2014) used a Bayesian mixed effect model to evaluate the reduction of challenging behavior
among two types of case conferences for people with dementia. Camacho et al. (2015) inves-
tigated the chance of demonstrating Ebola vaccine efficacy in the declining Ebola epidemic
using a Bayesian analysis approach. However, there is few discussion regarding Bayesian
design for SW-CRTs, particularly the Bayesian group sequential design. In this study, we
propose to investigate the incorporation of the Bayesian group sequential approach into SW-
CRTs through the predictive probability. The discussion of predictive probability for aiding
a decision making process can be found in many works (Choi and Pepple, 1989; Choi et al.,
1985; Gould, 2005; Spiegelhalter et al., 1986; Herson, 1979; Grieve et al., 1991; Johns and
Andersen, 1999). Our proposed method continuously examines the results from updated
data and determines whether the researchers can stop the study with a solid decision on
efficacy/futility or should continue the study. A distinct advantage of this method is that it
mimics the clinical decision-making process to make a rational decision. Based on interim
data, the chance (predictive probability) that the trial will show a conclusive result at the
end of study is evaluated. The decision to continue or stop the trial is made according to
the strength of this predictive probability.
28
In this chapter, (1) we describe the proposed Bayesian predictive probability method and
algorithms for making decisions in cross-sectional SW-CRTs; (2) we describe the criteria
for determining the design parameters subject to the constraints of design properties. For
example, the design parameters are searched within the given constraints such as type I
error and power of the test can be guaranteed; (3) we conduct extensive simulation studies
to examine the operating characteristics; (4) we illustrate the proposed method with a real
example; and (5) we conclude our proposed method and discuss the practical issues.
3.2. A Bayesian predictive probability approach
We illustrate our proposed method by considering a cross-sectional SW-CRT, which can
be easily extended to other types of SW-CRTs. Suppose there are S sequences. Within
each sequence, there are T = S + 1 time points for a standard SW-CRT and n clusters
at each time period (“step”). We assume the continuous measurements are collected from
different cohort of subjects within each cluster at predefined time points. Let Yijt be the
measurement obtained at time t (t = 1, . . . , T ) from subject j (j = 1, . . . , J) of the ith
cluster (i = 1, . . . , n). Thus JT is the cluster size and N = nJT is the total number of
subjects in this study. Let ps be the proportion of clusters assigned to the sth sequence with
∑S
s=1 ps = 1. A random effect model assumed for Yijt is
Yijt = µit + eijt, (3.1)
where µit = atλ+ uitζ + αi and
αi ∼ N(0, τ 2),
eijt ∼ N(0, σ2).
at is the indicator to specify the trend of time-specific intercept, for example, at = t for
linear trend and at = t
2 for quadratic trend. λ is the slope of time effect. uit is the treatment
indicator for subjects within the ith cluster at time t. ζ is the intervention effect. αi is the
random effect that describe the variation between clusters. eijt is the random error. It will
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be convenient to proof that the variance of Yijt is σ
2 + τ 2 and the intracluster correlation
coefficient (ICC) is τ
2
σ2+τ2
. Note that the observations are independent across clusters.
Suppose Y (t) = (Y111, . . . , Y11t, . . . , YnJ1, . . . , YnJt)
′
be the accumulated observations up
to time t. We also define Y (−t) such that
Y (T ) = Y (t) ∪ Y (−t).
That is, Y (−t) contains the collection of outcomes observed from time (t+1) to T and Y (T )
is the full observation at the end of the study.
If we rewrite the model (3.1) using observed data at time t in matrix form, it will be












β1 = (λ, ζ)
′, β2 = (α1, . . . , αn)
′. X1 is a nJt×2 matrix with each row (at, uit) corresponding
to the element in Y (t). X2 is a nJt× n cluster-specific matrix with each row being a vector
of length n with elements being 0 except the ith element being 1, for example, the first row of
X2 is (1, 0, . . . , 0)
′ corresponding to Y111 and the last row of X2 is (0, . . . , 0, 1)
′ corresponding
to YnJt. e is a vector of random error with elements corresponding to elements in Y
(t). Ic is
a c× c identity matrix, where c is an integer.
Suppose we design a cross-sectional SW-CRT to test the hypothesis H1 : ζ > ζ0, where ζ0
is the minimal target intervention effect. To apply the proposed approach to the SW-CRT at
every predefined time point, the predictive probability of declaring the intervention effective
at the end of the study given the current observations Y (t) will be calculated to support the
decision. Here we describe the steps for calculation of predictive probability as follows.
First, based on observed Y (t), we update knowledge about the parameters under the
Bayesian framework. Conceptually, prior distribution represents researchers’ opinion about
parameters before the study, likelihood represents learning from the study, and posterior dis-
tribution represents updated opinion about the parameters after the study. The likelihood
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model is shown in Equation (3.2). To further develop our Bayesian model, the priors for
the parameters of interest and nuisance parameters need to be specified. When no reliable
information regarding the parameters at the design stage or the inference based only on
observed data is desired, noninformative priors are preferred. Otherwise, the informative
priors including information from previous studies are recommended (Zhang et al., 2007).
To demonstrate our proposed method, we assume that observed data is highly informative
about the parameters of interest. And we can afford to be vague about the priors with con-
sidering the noninformative independent prior distributions as suggested by Gelman (2006)
and Gelman et al. (2013):
p (β1) ∝ 1;







p(τ) ∝ 1 with τ > 0,which is equivalent to p(τ 2) ∝ 1
τ
and can be interpreted as a limit of the folded-t family. Then we derive the joint posterior
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Y (t) −X1β1 −X2β2
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Because the closed-form marginal posterior distributions don’t exist, one of the most popular
Markov Chain Monte Carlo (MCMC) methods, Gibbs sampler, can be used here to obtain
posterior samples (Geman and Geman, 1987). All the full conditionals can be derived from
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the joint posterior distribution as follows:
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Second, we use updated knowledge of parameters to predict future observations Y (−t).
The posterior predictive distribution of Y (−t) is given by















where Y (−t) =
(
Y11(t+1), . . . , Y11T , . . . , YnJ(t+1), . . . , YnJT
)′
is a vector of predicted future ob-
servations. M11 and M22 are nJt × nJt and nJ(T − t) × nJ(T − t) matrices with di-
agonal elements being σ2 + τ 2 and off-diagonal elements being τ 2, respectively. M12 is a
nJt× nJ(T − t) matrix with all elements being τ 2, M21 is the transpose of M12.
Third, we have a “full” set of observations by combining observed Y (t) with predicted
Y (−t), based on which we determine whether to declare the intervention effective. Specifi-
cally, given the “full” observations (Y (t),Y (−t)), conclusions are made based on the posterior
probability of ζ exceeding the prespecified level ζ0, such as
P
(













is the marginal posterior distribution
of ζ. We compare P
(
ζ > ζ0|Y (t),Y (−t)
)
with a threshold θU to consider that whether the
intervention is efficacious at the end of the study. θU plays a pivotal role in screening out
the inefficacious intervention based on “complete” data at the end of the study.
Fourth, we repeat previous three steps to evaluate the predictive probability of the trial
being success at the end of study. Let PP denote the proportion of times that intervention
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is declared effective, indicating the chance of getting a statistically significant result at the
















In other words, PPt is the weighted average of positive trials with respect to the current
belief about the unknown parameters.
Fifth, we can use PPt to determine whether the trial should be stopped early due to
overwhelming evidence of efficacy/futility or continued because the current data are not yet
conclusive, based on the following decision rules:
• if PPt < πL, stop the trial and conclude the intervention ineffective;
• if PPt > πU , stop the trial and conclude the intervention effective;
• otherwise continue to time (t+ 1) until reaching the end of study.
Predictive probabilities formalize the decision making process by comparing them with
thresholds. In practice, we choose θU , πU , and πL as positive numbers between 0 and 1.
Then the decision for termination of the trial for efficacy or futility can be made if the trial
currently show superiority or inferiority and are likely to maintain it after remaining data
are collected. If πU = 1, the trial will stop for futility, but not for efficacy. Moreover, a
lower θU indicates that the null hypothesis will be rejected easily with increased power and
type I error. In contrast, a higher θU indicates that the null hypothesis will be rejected less
likely with decreased power and type I error. πU and πL are related to early stopping due to
efficacy and futility, respectively. A higher πL leads to easier stopping for lack of efficacy and
then causes decreased power and type I error. Similarly, a lower πU leads to easier stopping
for efficacy and then causes increased power and type I error.
3.3. Simulation studies
To illustrate our proposed predictive probability method, we conducted extensive simula-
tion studies. We assumed a cross-sectional SW-CRT with T = 5 time points (correspondingly
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S = 4 for a standard SW-CRT) and n clusters with J = 10 at each time point. We set in-
tervention effect ζ = 0.4 and slope of time effect λ = 0.1 with a linear trend indicator at = t
for t = 1, . . . , T . We also assumed an even transition scheme with ps =
1
S
for s = 1, . . . , S.
Let σ2 = 1 for random error and ρ = 0.05 for ICC. The hypothesis test we are interested in
is H1 : ζ > 0.1.
Here the detailed algorithm to conduct a Bayesian group sequential design based on
the predictive probability is described. In practice, it has been recommended to start the
Bayesian adaptive scheme after enough data have been collected to avoid premature decisions
based on spurious results. Without loss of generality, we assume that the adaptation start
from time t0 = 3. The trial proceeds as follows.
1. At Step t (t = t0, · · · , T − 1), collect observation Y (t) to prepare for adaptation.
(a) Simulate Y (−t) from posterior predictive distribution shown in (3.3) using drawed
parameter samplers.




. Conduct MCMC simulation to sam-
ple from posterior distribution p(ζ|Y ∗). Let ζ(l) (l = 1, · · · , L = 1000) be the
posterior samples of intervention effect from L iterations of simulation.







(d) If P (ζ > ζ0|Y ∗) > θU , declare the intervention effective and set decision indicator
D = 1, otherwise D = 0.
(e) Repeat (a)-(d) M times. Let Dm (m = 1, · · · ,M = 1000) be the mth decision
indicator. The predictive probability of the trial being success at the end of study







(f) Make adaptive decision to terminate or continue the trial at Step t according to
decision rules:
i. if PPt < πL, stop the trial early and conclude the intervention ineffective;
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ii. if PPt > πU , stop the trial early and conclude the intervention effective;
iii. otherwise continue to Step (t+ 1).
2. At Step T , collect the full observation Y (T ).





ζ(l) (l = 1, · · · , L = 1000) be the posterior sample from lth iteration of simulation.
(b) Numerically evaluate probability P
(
















(c) Stop trial. Declare the intervention effective if P
(
ζ > ζ0|Y (T )
)
> θU , declare
the intervention ineffective if P
(
ζ > ζ0|Y (T )
)
< θL, otherwise declare the trial
inconclusive.
To design a trial using proposed predictive probability method, we should search the op-
timal design parameters (n, θU , θL, πU , πL) to attain desirable design properties. Specifically,
the search can be implemented as follows.
1. Determine the range of n using frequentist methods.
2. Determine the range of thresholds (θU , θL, πU , πL).
3. For each combination of n and thresholds, summarize the empirical power, empirical
type I error, probability of early stopping, and expected number of subjects. The
expected number of subjects (E(N)) is the average of required numbers of subjects
from all simulations and can be calculated by nJT ′, where T ′ is the average of steps
needed in the simulations.
4. Search all combinations to identify the optimal design with desirable design character-
istics. The optimization criteria can be, but not limited to
• subject to desired power and type I error, find the optimal design with minimal
number of clusters (n) and expected number of subjects (E(N));
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• subject to fixed number of clusters (n) and desired type I error, find the optimal
design with maximal power.
To identify the optimal design, we set n = (15, 20, 25) because frequentist methods
suggest that n = 19 (Li et al., 2018) and n = 22 (Hooper et al., 2016). We set πU = 1
because we don’t want to stop the trial if the intervention shows early signs of efficacy. We
also set θL = (0.05, 0.10, 0.15, 0.20) even it only matters when trial continues to the last step.
We chose the following values for other thresholds: θU from 0.80 to 1.00 by 0.1 intervals and
πL from 0.05 to 0.70 by 0.05 intervals, as discussed by Zhou et al. (2008).
By searching over all combinations, we can identify the optimal design parameters to
achieve desirable design properties. Tables 3.1-3.3 show the empirical powers, empirical type
I errors, and expected numbers of subjects using proposed predictive probability method
when θL = 0.10. Actually, the effect of θL is very small because it only affects the study
when the study doesn’t stop early and continues to the last step. The results for θL =
(0.05, 0.15, 0.20) are very similar to results in Tables 3.1-3.3 and not shown here. Suppose
we desire a design with power at least 0.8 and type I error at most 0.05, the optimal choice
is (n = 20, θU = 0.87, πL = 0.70) in Table 3.2 with smallest expected number of subjects
being 925. The empirical power and type I error are 0.800 and 0.038, respectively. Using
frequentist method with above parameter settings and type I error of 0.038, the calculated
power is 0.796 (Li et al., 2018). Therefore, the proposed Bayesian method is comparable to
the frequentist method. On the other hand, suppose we desire a design with fixed number of
clusters n = 15 and type I error at most 0.05, the optimal choice subject to maximal power
is (θU = 0.96, πL = 0.05) in Table 3.1 with empirical power and type I error being 0.728 and
0.043, respectively.
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Table 3.1. Empirical power/type I error/expected number of subjects using predictive prob-
ability method with n = 15
θU πL = 0.05 πL = 0.20 πL = 0.40 πL = 0.70
0.80 0.927/0.204/744 0.905/0.185/732 0.853/0.145/714 0.758/0.094/682
0.81 0.925/0.194/744 0.903/0.175/732 0.847/0.137/713 0.747/0.087/679
0.82 0.921/0.188/743 0.896/0.170/730 0.837/0.133/710 0.740/0.082/677
0.83 0.914/0.177/743 0.890/0.159/729 0.825/0.125/707 0.726/0.077/673
0.84 0.904/0.165/742 0.881/0.148/729 0.819/0.117/706 0.716/0.073/671
0.85 0.900/0.153/742 0.874/0.136/726 0.811/0.109/704 0.702/0.068/668
0.86 0.896/0.145/740 0.866/0.132/724 0.804/0.100/701 0.696/0.065/666
0.87 0.884/0.138/740 0.855/0.124/723 0.795/0.095/699 0.679/0.060/661
0.88 0.875/0.128/739 0.846/0.115/720 0.786/0.088/697 0.665/0.056/657
0.89 0.869/0.114/737 0.835/0.101/718 0.775/0.077/694 0.649/0.050/653
0.90 0.860/0.103/737 0.824/0.090/715 0.763/0.068/691 0.640/0.044/650
0.91 0.847/0.094/735 0.811/0.082/711 0.748/0.061/688 0.630/0.037/646
0.92 0.836/0.085/733 0.801/0.073/710 0.732/0.055/683 0.615/0.029/642
0.93 0.825/0.072/730 0.784/0.063/706 0.724/0.047/680 0.591/0.025/635
0.94 0.793/0.063/729 0.743/0.057/698 0.685/0.042/673 0.567/0.022/630
0.95 0.765/0.053/724 0.721/0.050/695 0.662/0.036/669 0.536/0.019/621
0.96 0.728/0.043/720 0.689/0.037/688 0.628/0.026/661 0.505/0.014/613
0.97 0.689/0.030/714 0.650/0.026/681 0.591/0.022/651 0.464/0.009/600
0.98 0.629/0.018/704 0.582/0.015/669 0.529/0.013/639 0.394/0.008/581
0.99 0.525/0.011/690 0.491/0.011/652 0.439/0.010/617 0.300/0.005/557
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Table 3.2. Empirical power/type I error/expected number of subjects using predictive prob-
ability method with n = 20
θU πL = 0.05 πL = 0.20 πL = 0.40 πL = 0.70
0.80 0.959/0.174/995 0.945/0.152/985 0.923/0.119/975 0.850/0.062/943
0.81 0.956/0.164/995 0.939/0.142/984 0.920/0.114/974 0.846/0.058/942
0.82 0.954/0.154/994 0.937/0.130/983 0.917/0.103/973 0.841/0.055/940
0.83 0.951/0.143/993 0.935/0.120/983 0.913/0.094/972 0.836/0.050/938
0.84 0.948/0.134/993 0.932/0.116/982 0.905/0.086/969 0.829/0.048/936
0.85 0.944/0.127/993 0.925/0.110/981 0.897/0.076/967 0.821/0.047/933
0.86 0.942/0.119/993 0.921/0.103/980 0.894/0.070/966 0.808/0.046/928
0.87 0.940/0.112/992 0.918/0.099/980 0.891/0.064/965 0.800/0.038/925
0.88 0.930/0.101/991 0.914/0.091/979 0.887/0.058/964 0.790/0.035/922
0.89 0.928/0.092/990 0.910/0.080/978 0.882/0.052/963 0.777/0.030/916
0.90 0.922/0.080/990 0.901/0.068/975 0.869/0.045/958 0.766/0.028/911
0.91 0.916/0.075/988 0.895/0.060/973 0.856/0.042/954 0.750/0.026/905
0.92 0.899/0.067/986 0.881/0.053/971 0.836/0.042/950 0.721/0.024/895
0.93 0.891/0.061/985 0.874/0.051/970 0.825/0.038/945 0.701/0.020/889
0.94 0.875/0.053/984 0.855/0.043/966 0.804/0.033/941 0.666/0.018/877
0.95 0.854/0.046/981 0.827/0.037/962 0.777/0.025/935 0.631/0.015/864
0.96 0.832/0.040/978 0.808/0.029/957 0.757/0.021/928 0.606/0.012/853
0.97 0.806/0.025/974 0.776/0.019/951 0.720/0.013/914 0.568/0.010/840
0.98 0.761/0.017/969 0.725/0.013/936 0.655/0.010/893 0.499/0.005/816
0.99 0.649/0.008/957 0.619/0.008/913 0.542/0.006/857 0.406/0.003/780
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Table 3.3. Empirical power/type I error/expected number of subjects using predictive prob-
ability method with n = 25
θU πL = 0.05 πL = 0.20 πL = 0.40 πL = 0.70
0.80 0.993/0.214/1249 0.988/0.193/1246 0.968/0.158/1235 0.912/0.105/1208
0.81 0.989/0.202/1249 0.985/0.182/1246 0.966/0.153/1234 0.906/0.097/1204
0.82 0.985/0.185/1249 0.981/0.165/1246 0.963/0.140/1233 0.899/0.091/1201
0.83 0.985/0.178/1248 0.977/0.159/1244 0.962/0.136/1232 0.896/0.087/1199
0.84 0.983/0.171/1248 0.975/0.153/1244 0.957/0.128/1230 0.888/0.080/1196
0.85 0.982/0.162/1248 0.974/0.145/1243 0.954/0.125/1228 0.884/0.073/1194
0.86 0.975/0.152/1247 0.968/0.136/1241 0.948/0.116/1226 0.877/0.072/1191
0.87 0.974/0.140/1247 0.966/0.126/1241 0.942/0.105/1225 0.869/0.065/1188
0.88 0.973/0.132/1247 0.965/0.119/1240 0.937/0.099/1222 0.864/0.060/1186
0.89 0.966/0.121/1246 0.958/0.108/1239 0.933/0.093/1222 0.856/0.057/1182
0.90 0.966/0.111/1246 0.958/0.101/1237 0.928/0.087/1219 0.843/0.051/1175
0.91 0.958/0.098/1246 0.949/0.090/1235 0.921/0.076/1217 0.835/0.048/1171
0.92 0.952/0.091/1245 0.942/0.085/1232 0.911/0.071/1213 0.825/0.045/1167
0.93 0.946/0.083/1245 0.936/0.076/1231 0.898/0.064/1209 0.814/0.036/1162
0.94 0.937/0.071/1244 0.922/0.066/1226 0.883/0.051/1202 0.780/0.027/1147
0.95 0.926/0.066/1244 0.906/0.058/1222 0.871/0.045/1196 0.763/0.026/1139
0.96 0.906/0.049/1239 0.886/0.044/1217 0.847/0.036/1188 0.726/0.020/1123
0.97 0.895/0.035/1237 0.868/0.031/1210 0.826/0.025/1179 0.693/0.014/1108
0.98 0.851/0.024/1229 0.825/0.021/1198 0.781/0.017/1165 0.632/0.010/1080
0.99 0.790/0.014/1218 0.763/0.012/1177 0.704/0.010/1134 0.546/0.004/1042
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There are several observations about the effect of n, θU , and πL on empirical power and
expected number of subjects, as shown in Figure 3.1. First, a lower θU leads to a higher
empirical power (red). This is reasonable because a lower θU indicates less restrictive limits
to make the decision for efficacious intervention and then leads to a higher power. Second,
θU has a greater impact on empirical power and expected number of clusters than πL. For
example, the empirical powers are 0.927 and 0.525 when θU is 0.80 and 0.99 with fixed
πL = 0.05, respectively. On the other hand, the empirical powers are 0.927 and 0.758 when
πL is 0.05 and 0.70 with fixed θU = 0.80. Third, the empirical power increases with larger
number of clusters (n), which is consistent with the frequentist conclusion. Fourth, as the
number of clusters increases, the expected number of subjects increases noticeably because
it is a increasing function of n, even T ′ varies but within a small range between 3 and 5 in
this simulation study and T ′ is close to T because we set πU = 1 for not stopping early when
intervention is efficacious. Fifth, when θU = 1, the power is 0 based on the formula of PPt
and the trial stops at step t0 with expected number of subjects being nJt0.
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Figure 3.1. Empirical power (left) and expected number of subjects (right) using predictive
probability method with different combination of design parameters
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Figure 3.2 shows the trend of empirical power, probability of early stopping, and expected
number of subjects with increasing intervention effect using predictive probability method
with fixed θU = 0.96 and πL = 0.05. In the first panel, the gray dashed line is corresponding
to 0.05. The points at intervention effect 0.1 are the empirical type I errors for the trials
with different numbers of clusters (n). As intervention effect increases, the trial with larger
n attains a higher power. The second panel shows the probability of early stopping, which
decreases with the increased intervention effect. When intervention effect is small, say 0.1,
the intervention is inefficacious and the trial tends to have smaller PPt and easier stopping
with high probability. When intervention effect is large, say 0.4, the intervention is efficacious
and the trial is more likely to continue to the end of the study. Moreover, the probability
of early stopping for the trial with a higher power is smaller. In the third panel, a smaller
probability of early stopping leads to a larger expected number of subjects.
Figure 3.2. Empirical power, probability of early stopping, and expected number of subjects
using predictive probability method with different intervention effects
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3.4. A real application example
We illustrate our proposed method using a pragmatic cross-sectional SW-CRT, which is
established to evaluate the effect of combining interventions in preventing malnutrition and
reducing weight loss in hospitalized patients with acute tertiary care (Kitson et al., 2013).
The combining interventions incorporate nutrition screening, nutritional supplements, and
feeding assistance. The primary outcome is the weekly rate of change in patient’s body
weight. Suppose the wards are randomized into S = 4 sequences with J = 20 patients
at each of T = 5 time periods. The measurements will be collected at baseline and four
follow-ups. We assume the standardized intervention effect ζ = 0.3 and ICC = 0.03 based
on the Schultz et al. (2014). To choose the best design for this study by controlling power
and type I error, we set the required number of clusters n = (10, 15, 20) based on frequentist
method. Moreover, we set πU = 1 to avoid early stopping for efficacy and θL = 0.1. For each
n, we search the θU and πL space to find the optimal design with the desirable properties.
The results with n = 10 are shown in Table 3.4. Within each cell, there are empirical power,
empirical type I error, and expected number of subjects. If a trial with power ≥ 0.9 and type
I error ≤ 0.1 is desired, (θU , πL) = (0.89, 0.20) will be chosen with regards to the smallest
number of subjects 978. The corresponding empirical power, empirical type I error, and
probability of early stopping are 0.911, 0.092, 6.27%, respectively. If a trial with power ≥
0.8 and type I error ≤ 0.05 is desired, (θU , πL) = (0.93, 0.40) is the best choice with the
smallest number of subjects 937. The corresponding empirical power, empirical type I error,
and probability of early stopping are 0.804, 0.047, and 17.4%, respectively.
43
Table 3.4. Empirical power/type I error/expected number of subjects for a SW-CRT with
n = 10 and ζ = 0.3
θU πL = 0.05 πL = 0.20 πL = 0.40 πL = 0.70
0.8 0.971/0.195/997 0.951/0.177/988 0.921/0.147/972 0.829/0.088/935
0.81 0.971/0.184/997 0.949/0.170/987 0.918/0.135/970 0.822/0.082/932
0.82 0.969/0.177/997 0.947/0.161/986 0.912/0.127/968 0.815/0.075/929
0.83 0.968/0.165/997 0.943/0.146/985 0.908/0.119/967 0.806/0.072/925
0.84 0.964/0.153/997 0.940/0.134/984 0.901/0.110/965 0.801/0.067/923
0.85 0.962/0.140/996 0.937/0.125/983 0.891/0.101/961 0.791/0.062/919
0.86 0.957/0.132/996 0.931/0.119/982 0.884/0.096/959 0.778/0.059/915
0.87 0.954/0.121/996 0.923/0.106/979 0.875/0.083/956 0.769/0.052/911
0.88 0.943/0.112/995 0.916/0.097/979 0.869/0.077/954 0.758/0.049/907
0.89 0.936/0.105/994 0.911/0.092/978 0.861/0.073/952 0.747/0.046/904
0.90 0.924/0.094/993 0.897/0.080/974 0.847/0.066/949 0.731/0.045/900
0.91 0.913/0.085/991 0.887/0.072/971 0.838/0.061/946 0.719/0.041/894
0.92 0.899/0.080/989 0.873/0.070/967 0.817/0.057/940 0.699/0.035/887
0.93 0.887/0.073/987 0.858/0.059/963 0.804/0.047/937 0.674/0.030/878
0.94 0.867/0.063/986 0.835/0.052/960 0.787/0.040/930 0.648/0.025/869
0.95 0.840/0.050/982 0.814/0.039/956 0.762/0.033/921 0.625/0.021/860
0.96 0.820/0.040/978 0.790/0.033/949 0.729/0.025/912 0.593/0.015/850
0.97 0.782/0.030/972 0.753/0.025/940 0.689/0.022/899 0.544/0.009/832
0.98 0.725/0.018/963 0.692/0.016/925 0.626/0.013/881 0.492/0.008/813
0.99 0.639/0.011/949 0.607/0.010/896 0.542/0.009/854 0.405/0.007/779
44
In simulation studies and example, we set πU = 1 to avoid early stopping due to efficacy.
However, πU can be any number between 0 and 1 theoretically. Here we investigate the effect
of πU on empirical power, probability of early stopping, and expected number of subjects.
Suppose early stopping due to efficacy is allowed and (θU , πL) are fixed at (0.93, 0.40), which
lead to the optimal design in the example with power ≥ 0.8 and type I error ≤ 0.05. We set
πU from 0.80 to 1 by 0.02 intervals. The result in Figure 3.3 shows that empirical power does
not change much at different values of πU . However, the probability of early stopping and
expected number of subjects change noticeably at different values of πU . Specifically, the
probability of early stopping is decreasing with increased πU because a higher πU indicates
a stricter condition for early stopping for efficacy. Correspondingly, the expected number of
subjects is increasing.
Figure 3.3. Empirical power, probability of early stopping, and expected number of subjects
with varying πU
3.5. Discussion
In this study we proposed a predictive probability method to incorporate Bayesian adap-
tive approach to SW-CRTs, unlike frequentist design, which is a novel and ethical method
with flexibility of early stopping and efficiency of identification of effective or elimination of
ineffective treatment. This predictive probability method allows researchers to make conclu-
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sive result at the end of the study based on the current collected data. The proposed method
requires the specification of the number of clusters and thresholds (n, θU , θL, πU , πL). The
optimal choice should balance the practical considerations and trial efficiency. The design
parameters can be determined through a numerical search algorithm to yield desired frequen-
tist operating characteristics such as power, type I error, and expected number of subjects.
We conducted simulation studies to examining the performance of proposed predictive prob-
ability approach in cross-sectional SW-CRTs. The results show that the proposed method
achieves good operating characteristics. When evidence accumulates that the treatment is
effective or ineffective, it is wise to have a rule to stop the trial early.
Bayesian predictive probability framework allows existing knowledge about the param-
eters from previous studies or literatures to be formally incorporated into design through
prior specification, as well as updates information of parameters of interest using accumu-
lated data observed over time. For prior selection, if the prior information is reliable, we
can combine it with current study through informative priors. If the prior informative is
not reliable, we can apply noninformative priors, even it leads to similar or same estimates
as maximum likelihood method, it provides a natural way for making inference based on
likelihood and without the restriction of large sample theory and predefined design settings
(Zhou et al., 2008). In this study, we employed noninformative priors and limit inference
to the trial itself with no broader scope intended. However, it should not be considered as
the only alternative when prior knowledge is not available. Other priors leading to proper
posterior distributions can also worthy of consideration.
In this study, the financial constraints are not taken into consideration. Actually, ex-
pected cost for recruiting a subject and collecting one measurement at different time can
be employed to determine an optimal Bayesian design under practical considerations. For
example, we can calculate the expected cost for each combination of parameter settings and
then determine which design is the best through comparing costs. The cost function might
be set as C(T ′) = nJT ′, where we assume fixed cluster size (J) and equal weight for subjects
from different clusters. This is equivalent to the expected number of clusters in our study
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(E(N) = nJT ′). If different weight and varying cluster size are considered, the cost function
could be rewritten as C(T ′) = n
∑n
i=1 JiwiT
′, where wi is the weight for subjects from the
ith clusters with
∑n
i=1 wi = 1 and Ji is the cluster size for the ith cluster. If the relationship
between cost and stopping step T ′ is not linear, say quadratic, the cost function could be




























































































































s (Ω+ (J − 1)Φ)Ws.
We are only interested in σ2ζ , which is the (T + 1, T + 1)-component of Σ = A
−1EA−1. The
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When T = 4, we have v1 − ū =
(
0 1− p1 p3 0
)′
, v2 − ū =
(
0 −p1 p3 0
)′
and v3 − ū =
(
0 −p1 p3 − 1 0
)′







s=1 ps (vs − ū)
′
[Ω + (J − 1)Φ] (vs − ū)
ζ20J
[∑T






σ2 [p1 (1− p1)w11 + 2p1p3w12 + p3 (1− p3)w22]









∗ + (J − 1)Φ∗ with Y ∗ij = (Yij2, Yij3)′, Ω∗ = Corr(Y ∗ij ), and Φ∗ =
Corr(Y ∗ij ,Y
∗
ij′), where j 6= j′.
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A.2. Derivation of Equations (2.4) and (2.5)









because T = S + 1. Then
T∑
t=1











T (T − 2)











s=1 ps (vs − ū)
′
[Ω+ (J − 1)Φ] (vs − ū)
ζ20J
[∑T









s=1 (vs − ū)
′













s=1 (vs − ū)
′




A linear mixed-effect model with cluster and patient random effects would motivate a
correlation structure such that the within-subject (longitudinal) correlation Ω is compound
symmetric (CS) with off-diagonal elements being ρ1 and the between-subject correlation is
Φ = 11
′



















ρ1 · · · 1


+ (J − 1)



















(ρ1 + (J − 1) ρ2)























































[(S − 2) ρ1 + S (J − 1) ρ2 + 2] .
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s=1 (vs − ū)
′


















Sσ2 [(S − 2) ρ1 + S (J − 1) ρ2 + 2]
ζ20J (S
2 − 1) .
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A.3. Sample size for cross-sectional SW-CRTs
For cross-sectional SW-CRTs, the correlation structure can be modeled by Ω = 11
′
ρ +







s=1 ps (vs − ū)
′
[Ω+ (J − 1)Φ] (vs − ū)
ζ20J
[∑T








s=1 ps (vs − ū)
′ [

















t=1 (vst − ut)
]2





t=1 ut (1− ut)
]2 .
Under the special case of ps =
1
S











t=1 (vst − ut)
]2
























Sσ2 [(SJ − 2) ρ+ 2]
ζ20J (S
2 − 1) .
53






















































































































sGs [Ω + (J − 1)Φ]GsWs
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